EUVIMEDEUVIMED entdecken
Crossref

Risk analysis of hemolysis and establishment of prenatal prediction model in newborns due to maternal-fetal ABO blood type incompatibility

Hua Lu, Yi Zhu, Qi Gao, Luochuan Zhang, Chao Wan, Xiaomin Xu, Yijun Hou, Jun Yang, Feng Liu

Blood and Genomics · 30.06.2026 · 10 (1) · 46-51

DOI: 10.46701/bg.20260101297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood and Genomics, online erschienen am 30.06.2026. Verfasst von Hua Lu und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to investigate the impact of blood type, antibody titer, and pregnancy history on the incidence and severity of ABO hemolytic disease of the newborn (HDN). Data from 214 ABO HDN cases (2018–2021) were analyzed using elution tests for diagnosis and transcutaneous bilirubin for severity. The positivity rate was significantly higher in the OA group (86.73%) than in the OB group (53.47%, P < 0.01), although differences in bilirubin levels between the two groups were limited. An antibody titer of ≥ 64 was associated with a marked increase in HDN incidence; however no consistent correlation with bilirubin levels was observed. Pregnancy history showed no significant correlation. Logistic regression identified blood type and antibody titer as significant predictors of HDN incidence (odds ration [OR] = 6.09, P < 0.01; OR = 1.001, P < 0.05), whereas pregnancy history was not statistically significant (OR = 0.633, P > 0.05). The prediction model, expressed as logit(P) = ln[P/(1−P)] = 0.023 + 1.806 × blood type (1) + 0.001 × titer − 0.457 × pregnancy history (1), achieved an area under the curve (AUC) of 0.776, indicating moderate predictive accuracy. The study suggests that newborn blood type and maternal antibody titer are key factors for predicting ABO HDN incidence, though not its severity, while pregnancy history has limited relevance. This predictive model provides a moderately accurate tool for risk assessment.

Zitieren

APA

Lu, H., Zhu, Y., Gao, Q., Zhang, L., Wan, C., Xu, X., Hou, Y., Yang, J., & Liu, F. (2026). Risk analysis of hemolysis and establishment of prenatal prediction model in newborns due to maternal-fetal ABO blood type incompatibility. Blood and Genomics, 10(1), 46-51. https://doi.org/10.46701/bg.20260101297

Vancouver

Lu H, Zhu Y, Gao Q, Zhang L, Wan C, Xu X, et al. Risk analysis of hemolysis and establishment of prenatal prediction model in newborns due to maternal-fetal ABO blood type incompatibility. Blood and Genomics. 2026;10(1):46-51. doi:10.46701/bg.20260101297

BibTeX
@article{Lu2026,
  author = {Lu, Hua and Zhu, Yi and Gao, Qi and Zhang, Luochuan and Wan, Chao and Xu, Xiaomin and Hou, Yijun and Yang, Jun and Liu, Feng},
  title = {Risk analysis of hemolysis and establishment of prenatal prediction model in newborns due to maternal-fetal ABO blood type incompatibility},
  journal = {Blood and Genomics},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {46--51},
  doi = {10.46701/bg.20260101297}
}
Kostenlos starten →